Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
4.760
+0.310 (6.97%)
At close: Aug 13, 2025, 4:00 PM
4.540
-0.220 (-4.62%)
After-hours: Aug 13, 2025, 5:19 PM EDT
Lantern Pharma Market Cap
Lantern Pharma has a market cap or net worth of $51.34 million as of August 13, 2025. Its market cap has increased by 3.50% in one year.
Market Cap
51.34M
Enterprise Value
31.81M
1-Year Change
3.50%
Ranking
Category
Stock Price
$4.76
Market Cap Chart
Since June 11, 2020, Lantern Pharma's market cap has increased from $30.33M to $51.34M, an increase of 69.26%. That is a compound annual growth rate of 10.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 51.34M | 49.22% |
| Dec 31, 2024 | 34.40M | -26.05% |
| Dec 29, 2023 | 46.52M | -29.06% |
| Dec 30, 2022 | 65.58M | -26.55% |
| Dec 31, 2021 | 89.28M | -25.41% |
| Dec 31, 2020 | 119.69M | 294.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| Novartis AG | 234.72B |
| AstraZeneca | 232.33B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |